All Sauce from Weekly Sauce:

THURSDAY, April 4, 2024 (HealthDayNews) — Following disappointing trial results, the maker of a controversial ALS drug said it is pulling the medication off the market. In a statement issued Thursday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a large follow-up study, and the drug “will no longer be available for new…  read on >  read on >

Childbirth is a harrowing ordeal, and it’s being made worse by mistreatment from health care providers during labor, a new study says. More than one in every eight women are mistreated during childbirth, researchers found. Most commonly, women’s requests for help during labor were refused or ignored, results show. Nearly 8% of women said this…  read on >  read on >

Two newly discovered genetic variations can have a powerful effect on a person’s risk for obesity, a new report says. Variants in the gene BSN, also known as Bassoon, can increase risk of obesity as much as sixfold, researchers report April 4 in the journal Nature Genetics. These variants affect about 1 in every 6,500…  read on >  read on >